+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Chronic Post-Amputation Pain Management Market by Type, Treatment Type, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977892
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Chronic Post-Amputation Pain Management Market grew from USD 5.65 billion in 2023 to USD 5.96 billion in 2024. It is expected to continue growing at a CAGR of 5.66%, reaching USD 8.31 billion by 2030.

Chronic post-amputation pain (CPAP) management encompasses a range of techniques and treatments aimed at alleviating persistent pain experienced by amputees, often described as phantom limb pain or residual limb pain. The necessity for effective CPAP management arises from its impact on the quality of life and functional abilities of amputees, emphasizing its application across healthcare settings, rehabilitation facilities, and home care. Therapies may include pharmacological approaches, such as analgesics and antidepressants, nerve blocks, or advanced interventional treatments like nerve stimulation. The end-use scope extends to individual patients, hospitals, specialized pain clinics, and research institutions exploring innovative therapies.

Market insights reveal that key growth factors influencing this sector include an increasing prevalence of amputations due to diabetes and vascular diseases, advancements in pain management technologies, and rising awareness of specialized post-amputation care. The latest potential opportunities lie in the integration of AI and machine learning for personalized treatment plans and the development of non-invasive therapies such as virtual reality (VR) and augmented reality (AR) in rehabilitation programs. To leverage these opportunities, stakeholders should invest in R&D for innovative therapeutic technologies and collaborate with tech firms to combine digital health solutions with conventional medical practices.

However, limitations and challenges impacting market growth include high costs associated with advanced treatments, regulatory hurdles, and a lack of skilled professionals trained in emerging technologies. As such, innovation should focus on cost-effective solutions and user-friendly technologies for broader adoption. Areas ripe for exploration include biofeedback mechanisms, wearable tech for real-time pain monitoring, and genomics-based personalized pain management. Given the competitive and rapidly evolving nature of the CPAP management market, adaptability and continuous innovation, alongside strategic partnerships, will be crucial for businesses seeking sustainable growth and impactful market presence.

Understanding Market Dynamics in the Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising awareness of pain management options and better healthcare infrastructure
    • Increasing preference for pharmacological and non-pharmacological pain management therapies
    • Supportive government policies and healthcare reimbursement
  • Market Restraints
    • High cost of treatment options
  • Market Opportunities
    • Ongoing advancements in neuromodulation technologies
    • Need for patient-centric healthcare models emphasizing personalized treatment plans
  • Market Challenges
    • Limited availability of specialized medical professionals and issues associated with medication side effects

Exploring Porter’s Five Forces for the Chronic Post-Amputation Pain Management Market

Porter’s Five Forces framework further strengthens the insights of the Chronic Post-Amputation Pain Management Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Chronic Post-Amputation Pain Management Market

External macro-environmental factors deeply influence the performance of the Chronic Post-Amputation Pain Management Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Neuroma Pain
    • Phantom Limb Pain
    • Stump Pain
  • Treatment Type
    • Medication
    • Neuromodulation Techniques
    • Surgical Interventions
    • Therapy
      • Mirror Therapy
      • Physical Therapy
      • Psychological Therapy
  • End-Use
    • Home Care
    • Hospitals
    • Pain Clinics
    • Rehabilitation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
5.1.1.3. Supportive government policies and healthcare reimbursement
5.1.2. Restraints
5.1.2.1. High cost of treatment options
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in neuromodulation technologies
5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
5.1.4. Challenges
5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Chronic Post-Amputation Pain Management Market, by Type
6.1. Introduction
6.2. Neuroma Pain
6.3. Phantom Limb Pain
6.4. Stump Pain
7. Chronic Post-Amputation Pain Management Market, by Treatment Type
7.1. Introduction
7.2. Medication
7.3. Neuromodulation Techniques
7.4. Surgical Interventions
7.5. Therapy
7.5.1. Mirror Therapy
7.5.2. Physical Therapy
7.5.3. Psychological Therapy
8. Chronic Post-Amputation Pain Management Market, by End-Use
8.1. Introduction
8.2. Home Care
8.3. Hospitals
8.4. Pain Clinics
8.5. Rehabilitation Centers
9. Americas Chronic Post-Amputation Pain Management Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Chronic Post-Amputation Pain Management Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET DYNAMICS
TABLE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 41. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 45. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 63. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 67. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 75. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 99. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 116. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 120. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 136. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 148. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 152. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 156. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 184. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Chronic Post-Amputation Pain Management Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Advanced Arm Dynamics, Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • ATI Physical Therapy
  • B. Braun Melsungen AG
  • Einstein Healthcare Network
  • GlaxoSmithKline PLC
  • Memorial Healthcare System
  • Novartis AG
  • Pfizer Inc.
  • Physiopedia
  • Propel Physiotherapy
  • Select Medical Corporation
  • Smart Solutions Rehab Group
  • Teva Pharmaceutical Industries Ltd.
  • The Rehabilitation Hospital of Montana

Methodology

Loading
LOADING...

Table Information